Celesia, B. M. (2019) “IS IT SAFE AND COST SAVING TO DEFER THE CD4+ CELL COUNT MONITORING IN STABLE PATIENTS ON ART WITH MORE THAN 350 OR 500 CELLS/µL?”, Mediterranean Journal of Hematology and Infectious Diseases, 11(1), p. e2019063. doi: 10.4084/mjhid.2019.063.